Montelukast Teva (Montelukast Sodium)

Montelukast Sodium works by selectively blocking the cysteinyl leukotriene receptor CysLT1. By preventing leukotriene D4 from binding, it reduces bronchoconstriction, vascular leakage, and inflammatory cell recruitment in the airways, leading to improved breathing and decreased allergy‑related inflammation.

The appropriate dose of Montelukast Teva is determined by the prescribing healthcare professional based on the patient’s age, weight, disease severity, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for Montelukast during pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate individual circumstances before prescribing.

To place an order, submit an enquiry on the Montelukast Teva product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene‑modifier class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. While inhaled steroids directly reduce airway inflammation, montelukast provides a convenient once‑daily tablet that can be added to existing regimens, especially for patients with allergic components or difficulty using inhalers.

Montelukast Teva should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original blister pack or bottle, protect them from moisture, heat and direct sunlight, and keep out of reach of children.

Montelukast Teva is taken orally as a tablet, usually once daily in the evening. The tablet should be swallowed whole with a glass of water and can be taken with or without food. Patients should follow the dosing schedule prescribed by their clinician.

Serious adverse events, although rare, include neuropsychiatric reactions such as depression, suicidal thoughts, or mood changes, as well as severe allergic responses like angioedema and anaphylaxis. Any sudden changes in mood or signs of an allergic reaction should prompt immediate medical evaluation.

Montelukast Teva is contraindicated in individuals with known hypersensitivity to montelukast sodium or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in those who have experienced serious allergic reactions to leukotriene‑modifier drugs.